The Quadruple Aim[1] describes population health goals including decreasing costs, improving the patient experience, improving patient clinical outcomes, and improving the experience of providing care. Implementing new technologies into the current healthcare delivery system remains challenging and the Quadruple Aim goals play a role in the successful clinical adoption of... read more →
Jul
10
Mar
21
Kezia and Mike Fitzgerald, owners of CareAline Products were the recipients of a Pre-Seed Award and a 2017 Target Challenge award for solutions addressing the unintended removal or dislodgement of catheters or tubing. George Price of NEPDC caught up with Kezia this month to learn more about CareAline’s start, the... read more →
Jan
16
New England Pediatric Device Consortium (NEPDC) is pleased to announce four recipients of the organization’s latest round of seed awards. Recipients of Pre-Seed funding and in-kind service support include PathMaker Neurosystems, a bioelectronics medicine company developing the MyoAmplifierTM system, an advanced non-invasive platform that treats children with paralysis and muscle... read more →
Dec
20
Written by Scott Holson, NEPDC Project Leader and George Price, Lab Manager of the Duhaime Pediatric Neurosurgery Laboratory at Massachusetts General Hospital In many cases, the largest hurdles clinical innovators face when entering the medical device field involve the intangible constraints including time away from busy clinical schedules and a... read more →
Sep
26
UNYQ was the recipient of a 2016 Target Challenge award for their novel 3D printed scoliosis bracing technology, UNYQ AlignTM. In this interview with Product Manager, Sean Smith, NEPDC Program Administrator, Cassie Brugger, learned more about the product, UNYQ’s incredible progress, and what it was like to receive support through... read more →
Sep
08
For a fourth year, NEPDC www.NEPDC.org has announced funding and in-kind service support for solutions targeting a specific need in pediatric healthcare. NEPDC opened a call for devices addressing unintended removal or dislodgment of catheters or tubing in early June 2017. "In the primary care setting, when I see families trying to manage long term health... read more →
Jun
26
In this issue: NEPDC Accepting Proposals for 2017 Target Challenge Grant Opportunity Pre-Seed Awards Announced Participants in IPI's Catalyst Program Develop Solutions for Unplanned Extubations in Babies and Children
Jun
21
BALLERUP, Denmark and CAMBRIDGE, USA, 21 June 2017 - LEO Pharma announces an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical treatments in the skin. The hand-held aerosol device will be clinically tested on people with alopecia, where... read more →
Jun
06
New England Pediatric Device Consortium requests abstracts for advancements and improvements in unintended removal of catheters and tubing in children. Lebanon, NH – June 6, 2017 – NEPDC and partners have announced their annual Target Challenge grant opportunity for 2017. NEPDC is seeking abstract proposals for technologies that prevent or... read more →
Mar
31
In this issue: Integrating Industrial Design Resources into Early Product Planning Recent NEPDC Awardees Grant Deadline for next Pre-Seed opportunity is April 24, 2017